Karyopharm Therapeutics Inc. (NASDAQ:KPTI) appears in 68 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 15,607 | 6.73% | $0.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 0 | 930,000 | 0.00% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 1,376,325 | 196.34% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 151,397 | 37.09% | $0.00 |
| Affinity Asset Advisors, LLC | 31 Dec, 2025 | 0 | 889,575 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,466 | 0.00% | $0.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 0 | 517,297 | 1,897.85% | $0.00 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 31 Dec, 2025 | 0 | 310,020 | 0.00% | $0.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 0 | 440,000 | 0.00% | $0.00 |
| Ameriprise Financial Inc | 31 Dec, 2025 | 0 | 276,881 | 0.00% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | 303,370 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 94,445 | 101.24% | $0.00 |
| Exome Asset Management LLC | 31 Dec, 2025 | 0 | 295,541 | 0.00% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 148,793 | 0.00% | $0.00 |
| Boxer Capital Management, LLC | 31 Dec, 2025 | 0 | 252,536 | 0.00% | $0.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 0 | 112,359 | 317.95% | $0.00 |
| Catalio Capital Management, LP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 144,628 | 0.00% | $0.00 |